BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 25612140)

  • 41. [Revision needed of follow-up policy for Barrett's esophagus].
    Giard RW; Coebergh JW; Ouwendijk RJ
    Ned Tijdschr Geneeskd; 2002 Jan; 146(4):150-4. PubMed ID: 11845562
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endoscopic versus surgical therapy for early cancer in Barrett's esophagus.
    Dubecz A; Stein HJ
    Gastrointest Endosc; 2009 Oct; 70(4):632-4. PubMed ID: 19788980
    [No Abstract]   [Full Text] [Related]  

  • 43. Novel Screening Tests for Barrett's Esophagus.
    Codipilly DC; Iyer PG
    Curr Gastroenterol Rep; 2019 Jul; 21(9):42. PubMed ID: 31346777
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of low-grade dysplasia in Barrett's esophagus.
    Wani S
    Curr Opin Gastroenterol; 2012 Jul; 28(4):370-6. PubMed ID: 22508323
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Advances in diagnosis and management of cancer of the esophagus.
    Deboever N; Jones CM; Yamashita K; Ajani JA; Hofstetter WL
    BMJ; 2024 Jun; 385():e074962. PubMed ID: 38830686
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of brush cytology in the diagnosis of Barrett's esophagus: an analysis of eight cases.
    Padmavathy F; Siddaraju N; Sistla SC
    Diagn Cytopathol; 2011 Jan; 39(1):60-4. PubMed ID: 21162095
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New developments in the endoscopic surveillance of Barrett's oesophagus.
    Bergman JJ; Tytgat GN
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i38-42. PubMed ID: 15711007
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reflux disease and Barrett's esophagus.
    Koop H
    Endoscopy; 2000 Feb; 32(2):101-7. PubMed ID: 10696837
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HLA-DR expression in tumor epithelium is an independent prognostic indicator in esophageal adenocarcinoma patients.
    Dunne MR; Michielsen AJ; O'Sullivan KE; Cathcart MC; Feighery R; Doyle B; Watson JA; O'Farrell NJ; Ravi N; Kay E; Reynolds JV; Ryan EJ; O'Sullivan J
    Cancer Immunol Immunother; 2017 Jul; 66(7):841-850. PubMed ID: 28315927
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Barrett's esophagus and adenocarcinoma risk: the experience of the North-Eastern Italian Registry (EBRA).
    Rugge M; Zaninotto G; Parente P; Zanatta L; Cavallin F; Germanà B; Macrì E; Galliani E; Iuzzolino P; Ferrara F; Marin R; Nisi E; Iaderosa G; Deboni M; Bellumat A; Valiante F; Florea G; Della Libera D; Benini M; Bortesi L; Meggio A; Zorzi MG; Depretis G; Miori G; Morelli L; Cataudella G; d'Amore ES; Franceschetti I; Bozzola L; Paternello E; Antonini C; Di Mario F; Dal Bò N; Furlanetto A; Norberto L; Polese L; Iommarini S; Farinati F; Battaglia G; Diamantis G; Realdon S; Guido E; Mastropaolo G; Canova D; Guerini A; Franceschi M; Zirillo M
    Ann Surg; 2012 Nov; 256(5):788-94; discussion 794-5. PubMed ID: 23095623
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk stratification of patients with barrett's esophagus and low-grade dysplasia or indefinite for dysplasia.
    Thota PN; Lee HJ; Goldblum JR; Liu X; Sanaka MR; Gohel T; Kanadiya M; Lopez R
    Clin Gastroenterol Hepatol; 2015 Mar; 13(3):459-465.e1. PubMed ID: 25102445
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Barrett's esophagus: an update].
    González N; Parra-Blanco A; Cohen H
    Acta Gastroenterol Latinoam; 2012 Dec; 42(4):333-47. PubMed ID: 23383529
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Screening and surveillance for Barrett's esophagus: current issues and future directions.
    Choi SE; Hur C
    Curr Opin Gastroenterol; 2012 Jul; 28(4):377-81. PubMed ID: 22508325
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Barrett's esophagus-is it bad for your health?
    Falk GW
    Am J Gastroenterol; 2005 Dec; 100(12):2622-3. PubMed ID: 16393210
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Barrett's Esophagus: Diagnosis, Management, and Key Updates.
    Chang K; Jackson CS; Vega KJ
    Gastroenterol Clin North Am; 2021 Dec; 50(4):751-768. PubMed ID: 34717869
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Impact of endoscopic surveillance of Barrett's esophagus on survival of patients with esophageal adenocarcinoma].
    Incarbone R; Bonavina L; Bassi F; Peracchia A
    Chir Ital; 2002; 54(5):591-6. PubMed ID: 12469454
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Time to Challenge Current Strategies for Detection of Barrett's Esophagus and Esophageal Adenocarcinoma.
    Katzka DA; Fitzgerald RC
    Dig Dis Sci; 2020 Jan; 65(1):18-21. PubMed ID: 31754994
    [No Abstract]   [Full Text] [Related]  

  • 58. The Effect of Endoscopic Surveillance in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis.
    Codipilly DC; Chandar AK; Singh S; Wani S; Shaheen NJ; Inadomi JM; Chak A; Iyer PG
    Gastroenterology; 2018 Jun; 154(8):2068-2086.e5. PubMed ID: 29458154
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 2017 David Sun Lecture: Screening and Surveillance of Barrett's Esophagus: Where Are We Now and What Does the Future Hold?
    Falk GW
    Am J Gastroenterol; 2019 Jan; 114(1):64-70. PubMed ID: 30361622
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Endoscopic diagnosis of Barrett's adenocarcinoma].
    Yoshio H; Takashi Y; Mitsuyo H; Nobuhiko Y; Tatsurou T; Kazuhiko S; Yoko H; Shigemasa I; Hisanaga M; Osamu H; Katsuyoshi S; Seishi U; Matsushita H; Masahiko T
    Nihon Geka Gakkai Zasshi; 1999 Mar; 100(3):244-8. PubMed ID: 10379534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.